In a breakthrough for the way brain cancer is diagnosed and monitored, a team of researchers, lead by Anna M. Krichevsky, PhD, of the Center of Neurologic Diseases at Brigham and Women's Hospital (BWH), have demonstrated that brain tumors can be reliably diagnosed and monitored without surgery...
It's hard to tell what big pharma R&D departments are up to - even if you happen to work inside one of them. Pharma firms have not traditionally shared R&D info with rivals, for obvious reasons. But that can mean that big pharma companies spend billions of dollars on drugs competitors already...
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB (ActRIIB) class of molecules being developed...
Our guest this evening will be Mr. Daniel New. Mr New is vice chairman of the Constitution Party of Texas. TOPIC: How to Grow a Grassroots Organization BIO: Daniel New is a fifth generation Texan who has enjoyed 45 years of marriage (and with the same woman!), and together they have seven...
Earlier this week, House Energy and Commerce Committee Chairman Henry Waxman warned Secretary of State Hillary Clinton in a letter that approving the Keystone XL pipeline would be "a step in the wrong direction" and criticized the State Department's limited environmental impact statement about...
We need to buy a hybrid SUV or van that meets certain criteria. We have a couple of less than ideal choices available on the market NOW, but we don't know whether a model that would suit our needs better is in the pipeline to come out in a year or two. I am hoping that someone who has their...
Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing innovative immune-based biologics, announced that it has entered into two definitive license agreements with University Health Network (UHN) and The Hospital for Sick Children (SickKids) in Toronto, Ontario, granting...
Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing innovative immune-based biologics, announced that it has entered into two definitive license agreements with University Health Network (UHN) and The Hospital for Sick Children (SickKids) in Toronto, Ontario, granting...
The Bienville Democrat in Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines. According to the article, scientists are currently working on 861 new cancer...
The Bienville Democrat in Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines. According to the article, scientists are currently working on 861 new cancer...
The Bienville Democrat in Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines. According to the article, scientists are currently working on 861 new cancer...
The Bienville Democrat in Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines. According to the article, scientists are currently working on 861 new cancer...
The Bienville Democrat in Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companies have made great progress in treating cancers, introducing many new, breakthrough medicines. According to the article, scientists are currently working on 861 new cancer...